Theriva Biologics, Inc. (TOVX) stock
TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.14+0.00 (0.00%)
Close on Nov 17, 2026Market cap $6.42MP/E –Yield –
Theriva Biologics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Theriva Biologics's enterprise value was -$3.95M on Nov 11, 2026, against -$4.75M a year earlier. Over the last 5 years it ranged from -$43.23M to $136.17K, with a median of -$15.17M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$3.95M | – |
| 2025 | Dec 31, 2025 | -$5.36M | – |
| 2024 | Dec 31, 2024 | -$11.83M | – |
| 2023 | Dec 29, 2023 | -$23.76M | – |
| 2022 | Dec 30, 2022 | -$43.23M | – |
| 2021 | Dec 31, 2021 | -$38.97M | – |
| 2020 | Dec 31, 2020 | -$1.16M | – |
| 2019 | Dec 31, 2019 | -$12.92M | – |
| 2018 | Dec 31, 2018 | -$8.50M | -119.9% |
| 2017 | Dec 29, 2017 | $42.64M | -33.0% |
| 2016 | Dec 30, 2016 | $63.61M | -63.7% |
| 2015 | Dec 31, 2015 | $175.41M | +113.8% |
| 2014 | Dec 31, 2014 | $82.05M | +29.9% |
| 2013 | Dec 31, 2013 | $63.17M | +19.9% |
| 2012 | Dec 31, 2012 | $52.68M | +87.7% |
| 2011 | Dec 30, 2011 | $28.07M | – |
See a number that looks wrong?